Cancer Blood Products for Your Immuno-Oncology Research
Harnessing the immune system to fight cancer has been the long-standing objective of immuno-oncology research. Increased investments in cancer immunotherapy have led to exciting advances within this field, including a better understanding of cancer immunopathogenesis and the development of novel therapeutic approaches.
Choosing the right preclinical models is critical for improving lead candidate screening, investigating drug resistance mechanisms, and executing the right clinical development strategy. Improve your predictive preclinical models for drug screening or combination therapies by using physiologically relevant cancer blood products, and characterize patient response while facilitating reverse translational approaches.
Get the Cancer Blood Products You Need
STEMCELL Technologies offers a range of blood products from human patients with solid tumors (liver, kidney, etc.) or hematological cancers (myelofibrosis, acute myeloid leukemia, etc.).* Our frozen peripheral blood mononuclear cells (PBMCs) sourced from cancer patients are viable, functional, and ready for downstream assays. We also offer fresh peripheral blood and leukopaks from donors diagnosed with cancer, which can be further processed to isolate specific cell types.
STEMCELL can help you reduce experimental uncertainty and support your immuno-oncology research by providing quality off-the-shelf fresh and frozen cancer-sourced blood products and custom-isolated frozen products, such as plasma and serum, that consistently meet your requirements. Choose cancer cells based on your donor specifications and benefit from our range of characterization services to support your specific assays. You can also request information about the tumor stage and treatment history; however, we may not be able to share the exact details of a patient’s current therapeutic regimen.
Learn more about how we can work closely with you as your primary cells supplier.
Why Use Cancer Blood Products from STEMCELL Technologies?
- Choose cells that are more physiologically representative of cells in vivo.
- Access donor samples collected using regulatory authority-approved consent forms and protocols.
- Request custom products for non-standard cell types or collections with specific requirements.
- Reserve large numbers of cryopreserved cells and start experiments on your schedule with cells you've already tested.
- Reduce time spent collecting and culturing cancer-sourced primary cells.
Request an Offer for Human Primary Cells
Fill out this form to request information about introductory offers to try STEMCELL’s human primary cell products.
Request Offer >
Frequently Asked Questions on Primary Cells
Find answers to frequently asked questions on our primary cell products.
Learn More >Solid Tumor Cancer Blood Products
Our solid tumor offerings* include samples of peripheral blood collected from patients with solid tumors. These samples can be used to study tumor immunology as well as identify unique metastatic tumor markers when studying systemic effects of cancer on the immune system.
Product options include cancer-sourced whole blood, one-tenth leukopaks, frozen PBMCs, and custom-isolated frozen products, such as plasma and serum, for the following cancer types:
Hematological Cancer Blood Products
We offer primary cell products* for hematological cancers that begin in blood-forming tissue, such as the bone marrow, or in the cells of the immune system. Applications for these products range from evaluating how a drug may affect cancer cell growth, to comparing the cell functions in cancer patients and healthy donors.
Options include cancer-sourced frozen PBMCs and custom-isolated frozen products, such as plasma and serum, for the following cancer types:
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- Chronic Lymphocytic Leukemia (CLL)
- Chronic Myelogenous Leukemia (CML)
- Diffuse Large B Cell Lymphoma (DLBCL)
- Follicular Lymphoma (FL)
- Mantle Cell Lymphoma (MCL)
- Myelofibrosis (MF)
- Multiple Myeloma (MM)
Efficient Cell Isolation Technologies to Support Your Downstream Applications
It is important for you to choose cell separation technologies that will help you maximize efficiency while giving you the highly purified, functional cells you need for your specific application. Explore our manual and automated cell separation methodologies that can support your research needs while reducing experimental complexity.
EasySep™ Immunomagnetic Cell Separation
Isolate cells with a simple pour, in as little as 8 minutes.
RoboSep™ Automated Immunomagnetic Cell Separation
Isolate cells from up to 16 samples at once with minimal hands-on time.
RosetteSep™ Immunodensity Cell Isolation
Isolate human cell subsets directly from whole blood during density gradient centrifugation.
Protocols and Resources for Your Immuno-Oncology Research
Find protocols and technical resources to help you work with cancer cells in your research.
*Certain products are only available in select territories. Please contact your sales representative or the Product & Scientific Support team at techsupport@stemcell.com for further information.
